Underuse of Maintenance Therapies Highlights Need for Improved Care Strategies in Advanced Ovarian Cancer
Updated OVARIO Trial Results Reinforce Niraparib Plus Bevacizumab Maintenance for Advanced Ovarian Cancer
GLP-1 Receptor Agonists Show Promise as Adjunctive Treatment for Ovarian Cancer
Final PICCOLO Data Highlight Efficacy of Mirvetuximab Soravtansine in Later-Line Frα+ Platinum-Sensitive Ovarian Cancer
Improved Treatments, Prevention Drive Drop in US Ovarian Cancer Mortality: Muhammad Faizan, MBBS
Older, White, and Rural Women Remain at Risk Despite Decline in US Ovarian Cancer Mortality: Muhammad Faizan, MBBS
Evaluating Long-Term Safety Considerations for Targeted Therapies in Ovarian Cancer
The Effect of Adverse Event Profiles on Treatment Decisions
Streamlining Biomarker-Driven Therapy Decisions to Prevent Delays
The Importance of Multidisciplinary Collaboration in the Management of Ovarian Cancer
Overcoming Payer-Related Barriers for Optimal Care in Patients With Ovarian Cancer
ROSELLA Trial Highlights Safe, Biomarker-Free Option for Platinum-Resistant Ovarian Cancer: Brian Slomovitz, MD
ROSELLA Trial Offers New Insight Into Global Treatment Strategies for Ovarian Cancer: Brian Slomovitz, MD
Learnings From Key Clinical Trials in Ovarian Cancer
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care